| Literature DB >> 35215196 |
Josiane Etang1,2,3, Stanislas Elysée Mandeng1,4, Philippe Nwane1,4, Herman Parfait Awono-Ambene1, Jude D Bigoga5, Wolfgang Eyisap Ekoko1, Achille Jerome Binyang4, Michael Piameu1,6, Lili Ranaise Mbakop1,4, Narcisse Mvondo4, Raymond Tabue5,7, Rémy Mimpfoundi4, Jean Claude Toto1, Immo Kleinschmidt8,9,10, Tessa Bellamy Knox11, Abraham Peter Mnzava12, Martin James Donnelly13, Etienne Fondjo14.
Abstract
Understanding how multiple insecticide resistance mechanisms occur in malaria vectors is essential for efficient vector control. This study aimed at assessing the evolution of metabolic mechanisms and Kdr L995F/S resistance alleles in Anopheles gambiae s.l. from North Cameroon, following long-lasting insecticidal nets (LLINs) distribution in 2011. Female An. gambiae s.l. emerging from larvae collected in Ouro-Housso/Kanadi, Be-Centre, and Bala in 2011 and 2015, were tested for susceptibility to deltamethrin + piperonyl butoxide (PBO) or SSS-tributyl-phosphoro-thrithioate (DEF) synergists, using the World Health Organization's standard protocol. The Kdr L995F/S alleles were genotyped using Hot Ligation Oligonucleotide Assay. Tested mosquitoes identified using PCR-RFLP were composed of An. arabiensis (68.5%), An. coluzzii (25.5%) and An. gambiae (6%) species. From 2011 to 2015, metabolic resistance increased in Ouro-Housso/Kanadi (up to 89.5% mortality to deltametnrin+synergists in 2015 versus <65% in 2011; p < 0.02), while it decreased in Be-Centre and Bala (>95% mortality in 2011 versus 42-94% in 2015; p < 0.001). Conversely, the Kdr L995F allelic frequencies slightly decreased in Ouro-Housso/Kanadi (from 50% to 46%, p > 0.9), while significantly increasing in Be-Centre and Bala (from 0-13% to 18-36%, p < 0.02). These data revealed two evolutionary trends of deltamethrin resistance mechanisms; non-pyrethroid vector control tools should supplement LLINs in North Cameroon.Entities:
Keywords: Anopheles gambiae s.l.; Kdr 995F/S alleles; deltamethrin; insecticide resistance; malaria vector control; northern Cameroon; resistance management; synergists
Year: 2022 PMID: 35215196 PMCID: PMC8876678 DOI: 10.3390/pathogens11020253
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1Species distribution among Anopheles gambiae s.l. populations collected in 2011 and 2015.
Knockdown times and resistance status of Anopheles gambiae s.l. samples exposed to 0.05% deltamethrin.
| Locality and District | Year | N | Tkd50 (CI), min | Tkd95 (CI), min | Resistance Status |
|---|---|---|---|---|---|
| Kisumu | 2011 | 86 | 9.5 (8.4–10.8) | 17.3 (15.7–19.4) | S |
| 2015 | 86 | 9.4 (7.4–11.8) | 18.6 (14.7–19.7) | S | |
| Ouro-Housso/Kanadi | 2011 | 93 | 51.5 (30.7–64.2) | >60 | R |
| 2015 | 100 | >60 | >60 | R | |
| Be-Centre | 2011 | 82 | 23.5 (20.7–26.1) | >60 | SR |
| 2015 | 95 | 37.4 (32.3–44.0) | >60 | R | |
| Bala | 2011 | 75 | 41.2 (37.0–45.3) | >60 | R |
| 2015 | 87 | 27.6 (25.9–29.3) | >60 | R |
Resistance status was defined according to the WHO criteria [30]; i.e., mortality rates less than 90% were indicative of resistance, mortality rates between 90% and 97% suggested suspected resistance to be confirmed, while mortality equal to or greater than 98% indicated susceptibility. N: sample size; Tkd50 and Tkd95: knockdown times for 50% and 95% of the tested population; CI: confidence interval at 95%; min: minute; R: resistant; S: susceptible; SR: suspected resistance.
Figure 2Twenty-four-hour mortality rates (with a confidence interval at 95%) of Anopheles gambiae s.l. following exposure to 0.05% deltamethrin with or without 4% Piperonyl butoxide (PBO) and 7% SSS-tributyl-phosphoro-thrithioate (DEF) in 2011 and 2015. The resistance status was defined according to the WHO criteria [30]; i.e., mortality rates less than 90% were indicative of resistance, mortality rates between 90% and 97% suggested suspected resistance to be confirmed, while mortality equal to or greater than 98% indicated susceptibility. The red line at 90% mortality rate indicates the threshold for confirmed insecticide resistance. Comparisons of mosquito mortality rates to deltamethrin with versus without synergists were performed using the Mantel–Haenszel chi-square test.
Knockdown times and resistance status of Anopheles gambiae s.l. samples to deltamethrin with and without synergists.
| Locality and District | Year | Insecticide | N | Kdt50 (CI) (min) | Kdt95 (CI) (min) | Kdts50 (%) | Resistance Status |
|---|---|---|---|---|---|---|---|
| Kisumu | 2011 | Del | 86 | 9.5 (8.4–10.8) | 17.3 (15.7–19.4) | - | S |
| Del+PBO | 88 | 9.2 (7.8–10.8) | 18.4 (17.2–20.4) | 3.2 | S | ||
| Del+DEF | 82 | 8.8 (7.1–9.3) | 16.8 (14.5–20.3) | 7.4 | S | ||
| 2015 | Del | 86 | 9.4 (7.4–11.8) | 18.6 (14.7–19.7) | - | S | |
| Del+PBO | 90 | 8.9 (6.8–10.3) | 19.4 (16.2–21.3) | 5.3 | S | ||
| Del+DEF | 84 | 8.6 (7.1–10.7) | 18.8 (15.5–20.6) | 8.5 | S | ||
| Ouro-Housso/Kanadi Garoua district | 2011 | Del | 93 | 51.5 (30.7–64.2) | >60 | - | R |
| Del+PBO | 81 | 28.7 (21.0–35.0) | >60 | 44.3 | R | ||
| Del+DEF | 70 | 59.1 (47.3–24,854.6) | >60 | <0 | R | ||
| 2015 | Del | 100 | >60 | >60 | - | R | |
| Del+PBO | 68 | 40.3 (35.4–46.8) | >60 | 55.5 | R | ||
| Del+DEF | 74 | 52.4 (45.2–68.7) | >60 | 30.0 | R | ||
| Be-Centre | 2011 | Del | 82 | 23.5 (20.7–26.1) | >60 | - | SR |
| Del+PBO | 70 | 10.8 (6.6–14.6) | 41.8 (28.4–94.4) | 54.0 | S | ||
| Del+DEF | 86 | 6.8 (4.3–8.8) | 24.7 (18.6–42.3) | 71.1 | SR | ||
| 2015 | Del | 95 | 37.4 (32.3–44.0) | >60 | - | R | |
| Del+PBO | 82 | 14.9 (12.0–17.7) | >60 | 60.2 | R | ||
| Del+DEF | 88 | >60 | >60 | <0 | R | ||
| Bala | 2011 | Del | 75 | 41.2 (37.0–45.3) | >60 | - | R |
| Del+PBO | 51 | 38.1 (26.1–101.2) | 50 (23.0–249.0) | 7.5 | S | ||
| 2015 | Del | 87 | 27.6 (25.9–29.3) | >60 | - | R | |
| Del+PBO | 89 | 26.3 (24.6–28.0) | >60 | 4.7 | SR |
N: sample size; Del: deltamethrin; PBO: piperonyl butoxide; Kdt50 and Kdt95: knockdown times for 50% and 95% of the tested population; Kdts50: percent of knockdown time suppression; CI: confidence interval at 95%; min: minute; Tkd50R: time ratio required for knocking down 50% of individuals; R: resistant; S: susceptible; SR: suspected resistance.
Figure 3Frequency distribution of the different genotypes (per species) at position 995 of the Kdr locus among field-collected An. gambiae s.l. populations. Leu: Leucine position at position 995 (encoded by allele L995L); Phe: Phenylalanine position at position 995 (encoded by allele L995F); * Not determined because this species was not found.
Allelic frequencies (per species) at the Kdr 995 locus in field Anopheles gambiae s.l. samples in 2011 and 2015.
| Locality and District | Year | Species | N | Fs L995F (%) | Fc L995F (%) | |
|---|---|---|---|---|---|---|
| Ouro-Housso/Kanadi | 2011 |
| 20 | 37.50a | 50.00 | 0.88 |
|
| 18 | 61.11c | ||||
|
| 8 | 56.25g | ||||
| 2015 |
| 9 | 22.22a | 45.69 | ||
|
| 34 | 48.53c | ||||
|
| 15 | 53.33g | ||||
| Be-Centre | 2011 |
| 30 | 3.33a | 13.5 | 0.02 |
|
| 7 | 57.14c | ||||
|
| 0 | - | ||||
| 2015 |
| 42 | 35.71a* | 35.80 | ||
|
| 31 | 32.26c | ||||
|
| 15 | 43.33 | ||||
| Bala | 2011 |
| 40 | 0.00a | 0.00 | 0.01 |
|
| 0 | - | ||||
|
| 0 | - | ||||
| 2015 |
| 69 | 12.32a* | 18.10 | ||
|
| 9 | 44.44 | ||||
|
| 5 | 50.00 |
N: sample size; SS: homozygote susceptible; SR: heterozygote; RR: homozygote resistant; Fs: allelic frequencies of Kdr 995F of each species An. arabiensis, An. coluzzii and An. gambiae (s.s.); Fc: overall allelic frequencies of the Kdr L995F for the three identified species of the An. gambiae complex; a: non-significant difference in the Kdr L995F allelic frequency in An. arabiensis; c: non-significant difference in the Kdr L995F allelic frequency in An. coluzzii; g: non-significant difference in the Kdr L995F allelic frequency in An. gambiae; a*: significant difference in the Kdr L995F allelic frequency in An. arabiensis.
Putative insecticide resistance mechanisms in wild An. gambiae s.l. samples in 2011 and 2015.
| Locality | Year | Species | PBO Effect | DEF Effect | Resistance Status | |||
|---|---|---|---|---|---|---|---|---|
| Kdts50 | Mrv. | Kdts50 | Mrv. | |||||
| Ouro-Housso/Kanadi | 2011 | Aa **, Ac **, Ag ** | + | + | - | - | +++ | R |
| 2015 | Aa *, Ac **, Ag ** | ++ | ++ | + | + | ++ | R | |
| Be-Centre | 2011 | Aa *, Ac *** | ++ | + | ++ | +/- | ++ | RP |
| 2015 | Aa **, Ac **, Ag ** | ++ | - | - | - | +++ | R | |
| Bala | 2011 | Aa | +/- | + | N/A | N/A | - | R |
| 2015 | Aa *, Ac **, Ag ** | +/- | + | N/A | N/A | +++ | R | |
Aa: Anopheles arabiensis, Ac: Anopheles coluzzii; Ag: Anopheles gambiae; kdts50: knockdown time suppression; Mrv: mortality reversion; * presence of Kdr L995F at <25% frequency; ** presence of Kdr L995F at 25–40% frequency; *** presence of Kdr L995F at >50% frequency; +freq: Frequency; -: not detected; +/-: possible role in resistance to be confirmed; +: minor role in resistance; ++: Moderate role in resistance; +++: Major role in resistance; N/A: not applicable; R: confirmed resistance; SR: suspected resistance.
Figure 4Map of the North Cameroon Region showing the study health districts.